Effects of the theory of planned behavior and nudge strategy-based intervention on the adherence to anticoagulation treatment in patients with non-valvular atrial fibrillation

被引:6
|
作者
Ding, Yaoyao [1 ]
Jiang, Hui [2 ]
Liu, Jingzhe [1 ]
Chen, Dexin [1 ]
Yang, Fuguo [1 ]
机构
[1] Qingdao Univ, Sch Nursing, Qingdao 266071, Shandong, Peoples R China
[2] Univ Hlth & Rehabil Sci, Qingdao Hosp, Qingdao Municipal Hosp, Emergency Dept, Qingdao 266000, Shandong, Peoples R China
关键词
Non -valvular atrial fibrillation; Anticoagulation; The theory of planned behavior; Nudge; MEDICATION ADHERENCE; RISK;
D O I
10.1016/j.gerinurse.2023.01.023
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Non-valvular atrial fibrillation is associated with the incidence of thromboembolism. Current guidelines recommend preferential use of novel oral anticoagulants (NOAC) in patients with nonvalvular atrial fibrillation. Oral anticoagulation medication adherence rate was relatively low among discharged patients with non-valvular atrial fibrillation.Aim: To investigate the effects of the anticoagulation programs based on the theory of planned behavior and nudge strategy among patients with non-valvular atrial fibrillation.Methods: 130 patients with non-valvular atrial fibrillation were randomized to the intervention group or con-trol group, 72 patients in the intervention group, and 58 patients in the control group with a 6-month follow-up. Medication adherence, intention, attitude, perceived behavioral control and subjective norm and quality of life were assessed.Results: There were significantly differences in the intention, attitude and subjective norm between the two groups at one month, three months and six months follow-up (P <0.01). There were significantly differences in the perceived behavioral control between the two groups at three months and six months follow-up (P <0.01). The medication adherence scale score was higher in the intervention group than in the control group at three months and six months follow-up. However, there were no differences in quality of life between the two groups at one month, three months and six months follow-up.Conclusions: The program based on the theory of planned behavior and nudge strategy can improve medica-tion adherence in patients with non-valvular atrial fibrillation.(c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [31] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05): : 364 - 364
  • [32] Left atrial appendage thrombi formation in patients with non-valvular atrial fibrillation during anticoagulation therapy
    Kawabata, M.
    Goya, M.
    Sasaki, T.
    Maeda, S.
    Shirai, S.
    Nishimura, T.
    Yoshitake, T.
    Shiohira, S.
    Isobe, M.
    Hirao, K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 244 - 244
  • [33] Device-Based Strategy for Secondary Prevention of Stroke in Non-valvular Atrial Fibrillation Patients
    Sievert, H.
    Whisenant, B.
    Kar, S.
    Reddy, V.
    Doshi, S.
    CEREBROVASCULAR DISEASES, 2013, 35 : 757 - 757
  • [34] Novel antithrombotic effects of dabigatran in patients with non-valvular atrial fibrillation
    Tsuda, Keisuke
    Natori, Tatsunori
    Shimizu, Mie
    Ishigaku, Yoko
    Oi, Kiyotaka
    Narumi, Shinsuke
    Kamada, Asami
    Yoshida, Makiko
    Oura, Kazumasa
    Maeda, Tetsuya
    Terayama, Yasuo
    THROMBOSIS RESEARCH, 2020, 189 : 1 - 4
  • [35] Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation
    Jackson, Larry R.
    Kang, Amiee
    Noxon, Virginia
    Atreja, Nipun
    Hines, Dionne M.
    Hagan, Melissa
    Jiang, Jenny
    Atwater, Brett D.
    PLOS ONE, 2024, 19 (12):
  • [36] Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China
    Xiang, Xiao
    Cao, Yaying
    Sun, Kexin
    Song, Jing
    Tian, Yaohua
    Yin, Qiongzhou
    Juan, Juan
    Hu, Yonghua
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 255 - 261
  • [37] Oral Anticoagulation Therapy in Patients Hospitalized With Non-Valvular Atrial Fibrillation: A Nationwide Cohort Study
    Lee, Kuan Ken
    Bing, Rong
    Astengo, Federica
    Perez, Jesus
    Anand, Atul
    Hill, Nathan
    Bloor, Nicholas
    Lister, Steven
    McAllister, David
    Mills, Nicholas L.
    Shah, Anoop S.
    CIRCULATION, 2019, 140
  • [38] Anticoagulation therapy in patients with non-valvular atrial fibrillation hospitalized in the Department of Medicine in the NOACs era
    Atamna, A.
    Suki, M.
    Kena'any, H.
    Elis, A.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2018, 111 (07) : 461 - 465
  • [39] Outcomes After Switching Anticoagulation From Warfarin to DOACs in Patients With Non-valvular Atrial Fibrillation
    Ueda, Shinichiro
    Morimoto, Takeshi
    CIRCULATION, 2019, 140
  • [40] The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation
    Van den Ham, H. A.
    Klungel, O. H.
    Leufkens, H. G. M.
    Van Staa, T. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 107 - 115